Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this Non- Interventional Study (NIS) is to describe the use of atypical antipsychotics in subjects with Schizophrenia during the hospitalisation due to acute psychotic episode by evaluation of drug, dose and mode of administration of the medication.
RECONNECT-S BETA
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects who are hospitalized due to acute psychotic episode. | All subjects who are hospitalized due to acute psychotic episode. The subjects should be managed according to normal clinical practice until discharge time. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Use of atypical antipsychotic(s) during hospitalisation. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Daily dosage of atypical antipsychotic(s) during hospitalisation. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Mode of administration of atypical antipsychotic(s) during hospitalisation. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Measure | Description | Time Frame |
|---|---|---|
| Percent of patients with atypical antipsychotic as monotherapy. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Percent of patients with combinations of antipsychotics. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Psychiatric Institutes
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Talaat Matar, CONSULTANT PSYCHIATRIST | Obaid Alla Hospital,Ras Al Khaima,UAE | Study Chair |
| Tarek Darwish, CONSULTANT PSYCHIATRIST | Sheikh Khalifa Medical City(SKMC), Abudhabi,UAE | Study Chair |
| Sohail Khan, CONSULTANT PSYCHIATRIST | Jeddah Psychiatric hospital,Jeddah, Saudi Arabia | Study Chair |
| Tarek Okasha, PROFESSOR | Ain Shams University, Cairo, Egypt | Study Chair |
| Mohamed Nasr, PROFESSOR | Cairo University, Egypt | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Cairo | Egypt | ||||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
The data will be collected at one visit at the moment of discharge from the hospital. |
| Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Main criteria of an antipsychotic's selection during hospitalisation expressed as percentage. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Use of psychometric scales in day to day practice in therm of evaluation of the disease symptoms and thus efficacy of the treatment. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Description of the usage of concomitant psychiatric medication (other than atypical antipsychotic) during the hospitalization. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Relationship between medication used during the hospitalization and maintenance therapy recommended upon discharge. | The data will be collected at one visit at the moment of discharge from the hospital. | Hospitalisation period, an expected average of 3 weeks (variable per patient). |
| Dammam |
| Saudi Arabia |
| Research Site | Jeddah | Saudi Arabia |
| Research Site | Riyadh | Saudi Arabia |
| Research Site | Abu Dhabi | United Arab Emirates |
| Research Site | Dubai | United Arab Emirates |
| Research Site | Ras al-Khaimah | United Arab Emirates |